Cytek Investor Presentation Deck

Our FSP Platform Allows Us to Address the Broader Cell Analysis Market $1.0B Single Cell Analysis $1.6B Cell Counting & QC CYTEK TRANSCEND THE CONVENTIONAL $8B Initial TAM (Cell Analysis Market in 2019 Addressable by Flow Cytometry) $1.9B Cell Proliferation $3.0 B Cell ID $1.1B Cell Structure $1.3B Target ID $1.3B Cell Interaction $8B Additional TAM (Cell Analysis Market in 2019 Not Currently Addressable by Flow Cytometry) $2.4B Cell Viability $2.4B Cell Signaling $23B Long-Term TAM (Total Cell Analysis Market in 2024) Marine Biology Water Supply Contamination 8) Alternative Biofuels

View entire presentation